Hypoxic respiratory failure from acute respiratory distress syndrome (ARDS) is the leading cause of mortality in patients with Coronavirus disease 2019 (COVID-19). Emerging evidence suggests that endothelial cells are essential contributors to the initiation and propagation of severe COVID-19 disease. This study discusses the current insight into the link between endothelial cells, viral infection and inflammatory changes and propose novel therapeutic strategies… Read more.
Patients with cancer have a higher risk of developing severe COVID-19 disease. Additionally, immune response after vaccination is lower. This study examined short-and long-term vaccine effectiveness and protection levels after two doses of COVID-19 vaccine in cancer patients at real world population level. The results indicate that cancer patients receive a lower level of protection from the vaccines, and that this protection wears off faster than it does in the general population… Read more.
Telehealth has been widely adopted during the SARS-CoV-2 pandemic, and some of its elements will likely be integrated into the long-term cancer care. This study assessed patient perception of telehealth among gynaecologic cancer survivors. Although these patients were satisfied with the telehealth care they received, the majority thought a physical examination was critical to detect cancer recurrence… Read more.
The COVID-19 pandemic caused major disruptions in the treatment of cancer and other conditions due to restrictions in access to care and the prioritising of treatment of COVID-patients. A recent study from the USA now indicates that the pandemic also likely caused new cancer diagnoses to be delayed, a situation that could lead to worse prognoses for patients. The findings recently appeared in CANCER, a journal of the American Cancer Society… Read more.
Next to the lockdowns that halted ongoing cancer care and treatments, the coronavirus disease-19 (COVID-19) also had its impact on cancer clinical trials. For future pandemic preparedness, an international panel of oncology experts discussed about possible solutions to keep clinical trials going… Read more.